A candidate anti-leprosy vaccine from ICRC bacilli.
Deo
M G
MG
Cancer Research Institute, Parel, Bombay, India.
Chaturvedi
R M
RM
Kartikeyan
S
S
D000293:Adolescent; D000328:Adult; D001428:Bacterial Vaccines / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003429:Cross Reactions; D005260:Female; D006801:Humans; D007167:Immunotherapy; D007194:India; D007223:Infant; D007917:Leprostatic Agents / Q000627:therapeutic use; D007918:Leprosy / Q000517:prevention & control* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009161:Mycobacterium / Q000276:immunology*; D009166:Mycobacterium leprae / Q000276:immunology*
D001428:Bacterial Vaccines; D007917:Leprostatic Agents; C060596:anti-leprosy vaccine